Cognate BioServices Revenue and Competitors

Claim your profile

Hanover, MD USA

Location

$7M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cognate BioServices's estimated annual revenue is currently $38.8M per year.(i)
  • Cognate BioServices received $Undisclosed in venture funding in February 2018.
  • Cognate BioServices's estimated revenue per employee is $193,750
  • Cognate BioServices's total funding is $7M.

Employee Data

  • Cognate BioServices has 200 Employees.(i)
  • Cognate BioServices grew their employee count by -35% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.1M400%$17.5MN/A
#2
$4.4M57-49%$10.5MN/A
#3
$18.3M1180%$69.4MN/A
#4
$12.6M8129%N/AN/A
#5
$2.6M4146%N/AN/A
#6
$1.2M160%$40MN/A
#7
$6.8M44N/AN/AN/A
#8
$2.2M3431%N/AN/A
#9
$1.6M10-23%N/AN/A
#10
$1.4M180%$34.7MN/A

Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development of cell-based products. The combination of highly experienced staff, cGMP facilities and international track record makes Cognate one of the most experienced contract manufacturers of cell based products in the world today.

keywords:N/A

$7M

Total Funding

200

Number of Employees

$38.8M

Revenue (est)

-35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cognate BioServices News

2021-01-27 - Cognate BioServices and Nucleus Biologics announce partnership in Cell and Gene Therapies

MEMPHIS, Tenn., Jan. 27, 2021 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and Nucleus Biologics, LLC, The Cell Performance Company™, announced today a partnership for custom and commercial medias and delivery system ...

2021-01-14 - Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe

MEMPHIS, Tenn., Jan. 14, 2021 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready, global CDMO in the Cell and Gene Therapy industry, announced today its plans to expand cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities, and increase o ...

2020-08-20 - Cognate BioServices Announces the Appointment of Two Independent Board Members

MEMPHIS, Aug. 20, 2020 /PRNewswire/ -- Cognate BioServices, Inc. announced today the appointments of Timothy Moore and Steven Kasok as independent non-executive members of its Board of Directors. "We are excited to welcome Tim Moore and Steve Kasok to our Board of Directors. They bring decade ...

2019-09-08 - EW Healthcare invests in Cognate BioServices

EW Healthcare Partners has invested in Cognate BioServices. Financial terms weren't announced. Cognate BioServices is a contract ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M215-3%N/A
#2
$84.6M2334%N/A
#3
$15M23522%N/A
#4
$47.1M2388%N/A
#5
$75.7M2556%N/A

Cognate BioServices Funding

DateAmountRoundLead InvestorsReference
2018-02-21$UndisclosedUndisclosedTennenbaum Capital Partners, LLCArticle